* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Essex Bio-Technology's PEG Ratio or its related term are showing as below:
HKSE:01061'
s PEG Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.63 Max: 1.78
Current: 1.6
During the past 13 years, Essex Bio-Technology's highest PEG Ratio was 1.78. The lowest was 0.29. And the median was 0.63.
HKSE:01061's PEG Ratio is ranked better than 54.42% of 362
companies
in the Drug Manufacturers industry
Industry Median: 1.765
vs HKSE:01061: 1.60
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Essex Bio-Technology PEG Ratio Historical Data
The historical data trend for Essex Bio-Technology's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Essex Bio-Technology's PEG Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Essex Bio-Technology's PEG Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Essex Bio-Technology's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Essex Bio-Technology (HKSE:01061) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Essex Bio-Technology PEG Ratio Related Terms
Thank you for viewing the detailed overview of Essex Bio-Technology's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01061 has been successfully added to your 